Navigation Links
OHSU turns innovations into commercial opportunities at record pace
Date:10/23/2007

cialization activities to the next level by increasing targeted research collaborations with industry and potential investors.

The five FY 2007 OHSU startups are:

  • Molecular MD is a molecular diagnostics company specializing in clinical development and commercialization of state-of-the-art assays used to diagnose specific cancers and to monitor the ongoing effectiveness of therapy. In partnership with BioCatalyst International, the company was founded by OHSU scientists, notably Brian Druker, M.D., director of the OHSU Cancer Institute, and Michael Heinrich, M.D., acting head of the division of hematology and oncology in the OHSU School of Medicine. Druker is internationally recognized for his role in the clinical development of Gleevec (Imatinib), the first molecular-targeted medication to prove effective against chronic myelogenous leukemia (CML). Heinrich was the first to identify mutations in platelet-derived growth factor receptors (PDGFR) as the cause of gastrointestinal stromal tumors in specific patient populations. MolecularMDs focus is on developing partnerships with pharmaceutical companies and physicians by providing them with clinically relevant molecular tests that help optimize therapy and improve patient outcomes. [ For more information about Molecular MD, go to http://www.molecularmd.com ]

  • ID Biopharma which was spun off by Virogenomics Inc., an earlier OHSU startup -- was created to accelerate the development of vaccines, therapeutics and diagnostics to fight infectious diseases. When it was formed it also brought in additional OHSU-developed technologies. The company is unique among biotechnology and pharmaceutical companies in focusing on infectious diseases. ID Biopharma will function as the commercialization accelerator for the Oregon Translational Research and Drug Development Institute (OTRADI), which it worked with the states four research universitie
    '/>"/>

Contact: Harry Lenhart
lenharth@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. Lack of enzyme turns fat cells into fat burners
2. Programmable cells: Engineer turns bacteria into living computers
3. Gene therapy turns off mutation linked to Parkinsons disease
4. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine
5. Jefferson researchers uncover new way nature turns genes on and off
6. Leukemia drug turns mini-molecules up, cancer genes down
7. Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays
8. Why were the HIV prevention trials in commercial sex workers abandoned?
9. Agilent Technologies Introduces First Commercial Mouse Microarray for Comparative Genomic Hybridization Research
10. Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
11. Commercial fishing causes dangerous fluctuations in fish populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... with critical security-authentication needs, today announced the beginning of ... (FFD) solution. The company, based in ... at the three-day Connect:ID Expo, which began here today ... NexID said version 2.0 of its SDK boosts the ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update following the ... wallet. SoundView was one of the selected user groups to provide ... in multiple scenarios and outlets. Soundview shares ... both debit and credit card payments.  Soundview ... meets their plans in 2015, it would push our IV ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
... Taking aim at a leading cause of ... at the Massachusetts Biologic Laboratories (MBL) of the University of ... that neutralizes the Hepatitis C virus (HCV). The new ... infection by the virus in a pre-clinical animal model of ...
... details of a membership agreement with BioMed Central to ... researchers. Pfizer,s BioMed Central membership arrangement means that ... researcher employed or funded by Pfizer when they submit ... peer-reviewed open access journals. By funding open access publication ...
... of Guam Associate Professor Laurie Raymundo is senior editor ... and management of coral diseases, " Coral Disease Handbook: ... summarizes the most recently developed methods for studying the ... the book is a set of identification cards for ...
Cached Biology News:Novel antibody prevents infection by hepatitis C virus 2Novel antibody prevents infection by hepatitis C virus 3
(Date:3/26/2015)... -- BioNano Genomics, Inc., the leader in genome mapping, announced ... commercial officer. Salyer has more than 20 years of ... sciences. At BioNano, Salyer will oversee the commercialization of ... assemble a comprehensive view of complex genomes to help ... located in the United States , ...
(Date:3/26/2015)... ReliantHeart, Inc., an innovative supplier of advanced mechanical ... transit-time flow measurement solutions, are collaborating on a miniature ... the HeartAssist5® Left Ventricular Assist Device (LVAD). ... and peace of mind. , The Transonic flow ... 1/6th of the power required by earlier flow board ...
(Date:3/25/2015)... Russia,s pharmaceutical market is one of the ... to its absolute size, plus a growing economy and ... from Business Monitor International. The Russian market is set ... pharmaceutical market, with growth estimates around 10-15% annually reaching ... About Green Cross Green Cross ...
(Date:3/25/2015)... London, UK (PRWEB) March 25, 2015 ... pervasive uptake of smartphones have fuelled social media ... population being currently engaged in social networking. Insurance ... exhaustively to communicate with clients and promote a ... the globe over are increasingly exploiting social networking ...
Breaking Biology Technology:BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 2Social Media Role in Global Insurance Industry Examined by Timetric in New Market Research Report Published at MarketPublishers.com 3
... Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today ... months ended June 30, 2008., "We continue ... stated Patrick J. McEnany, Catalyst,s Chief Executive Officer.,"In ... in our U.S.,Phase II clinical trials evaluating CPP-109 ...
... TAIAN CITY, Shandong, China, Aug. 14 /Xinhua-PRNewswire-FirstCall/ --,China ... Biologic,",the "Company"), one of the leading plasma-based pharmaceutical ... reported financial results,for the second quarter ended June ... -- Revenues increased 35.1% year-over-year to $11.9 ...
... 14 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: CHBT) ... the manufacture,research, development, marketing and distribution of probiotics ... quarter of its 2009,fiscal year, ended June 30, ... -- Net sales increased 19.5% year-over-year to $11.4 ...
Cached Biology Technology:Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 2Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 3Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 4Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 5China Biologic Products Reports Second Quarter 2008 Results 2China Biologic Products Reports Second Quarter 2008 Results 3China Biologic Products Reports Second Quarter 2008 Results 4China Biologic Products Reports Second Quarter 2008 Results 5China Biologic Products Reports Second Quarter 2008 Results 6China Biologic Products Reports Second Quarter 2008 Results 7China Biologic Products Reports Second Quarter 2008 Results 8China Biologic Products Reports Second Quarter 2008 Results 9China Biologic Products Reports Second Quarter 2008 Results 10China Biologic Products Reports Second Quarter 2008 Results 11China Biologic Products Reports Second Quarter 2008 Results 12China Biologic Products Reports Second Quarter 2008 Results 13China Biologic Products Reports Second Quarter 2008 Results 14China Biologic Products Reports Second Quarter 2008 Results 15China-Biotics, Inc. Reports First Quarter 2009 Financial Results 2China-Biotics, Inc. Reports First Quarter 2009 Financial Results 3China-Biotics, Inc. Reports First Quarter 2009 Financial Results 4China-Biotics, Inc. Reports First Quarter 2009 Financial Results 5China-Biotics, Inc. Reports First Quarter 2009 Financial Results 6China-Biotics, Inc. Reports First Quarter 2009 Financial Results 7China-Biotics, Inc. Reports First Quarter 2009 Financial Results 8China-Biotics, Inc. Reports First Quarter 2009 Financial Results 9China-Biotics, Inc. Reports First Quarter 2009 Financial Results 10China-Biotics, Inc. Reports First Quarter 2009 Financial Results 11
...
RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
2'-Fluorine-CTP (2'-F-CTP) is readily incorporated into transcripts by T7 and SP6 R&DNA™ Polymerase and is available separately....
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
Biology Products: